Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 28 for “"Navitoclax"”.
-
Pharmacological Senolysis as a New Therapeutic Approach for the Prevention of Doxorubicin-Induced Cardiotoxicity
… la administración del fármaco senolítico, navitoclax, como opción terapéutica para prevenir la cardiotoxicidad asociada al tratamiento antitumoral con doxorrubicina. La exposición a doxorrubicina afecta gravemente a la población de células cardíacas tanto en ratones como en corazones …
-
Preclinical evaluation of senescence-based strategies to improve cancer therapy
… de su eliminación mediante el uso del senolítico navitoclax. Comprobamos que el tratamiento sistémico con palbociclib en un modelo ortotópico de cáncer de mama en ratones induce senescencia en las células endoteliales vasculares, generando un endotelio alterado funcionalmente que favorece la …
-
Der antiproliferative Effekt des RNA-Polymerase I Inhibitors CX-5461 in Zellen kolorektaler Karzinomzelllinien auf zellulärer und molekularer Ebene
… mit dem Bcl-Inhibitor und Senotlytikum Navitoclax in Apoptose überführen. Das kombinierte Strategiekonzept demonstriert, dass der pro-proliferative Phänotyp von Tumorzellen mit CX-5461 durch Induktion von Seneszenz effektiv gestoppt werden kann, um anschließend diese Zellen mit dem …
-
Mesoporous silica and gold-based nanodevices: new controlled delivery platforms for biomedical applications
… la liberación controlada de dos inhibidores (navitoclax y S63845) de las proteínas anti- apoptóticas de la familia Bcl-2. Este sistema se ha diseñado con el objetivo de superar la resistencia a navitoclax en un modelo celular de cáncer de mama triple negativo. En concreto, se han preparado …
-
Ribosomal Stress in the Pathogenesis and Treatment of T-cell Acute Lymphoblastic Leukemia
… to evaluate the combination of idasanutlin with navitoclax, a potent Bcl-2/Bcl-XL inhibitor. Indeed, this combination induced robust synergistic killing of T-ALL PDX lines in vitro. We next examined the in vivo response of four different T-ALL xenografts. Notably, a marked synergic response to …
-
Molecular interactions and signaling mechanisms of the oncogenic fusion protein DNAJ-PKAc in fibrolamellar carcinoma
… damaging agent etoposide and the Bcl-2 inhibitor navitoclax show that the DNAJ-PKAc/Hsp70/BAG2 axis contributes to chemotherapeutic resistance in a cellular model of FLC. Wildtype AML12 cells were susceptible to each drug alone and in combination. In contrast, AML12DNAJ-PKAc cells were moderately …
-
NOVEL STRATEGIES IN HEAD AND NECK TUMOR THERAPY; CONTRIBUTION OF SENESCENCE IN THERAPY RESPONSE, AND RESISTANCE DEVELOPMENT AFTER CISPLATIN TREATMENT
… we evaluated the effectiveness of ABT-263 (Navitoclax) and ARV-825, in the elimination of senescent tumor cells after cisplatin treatment. Navitoclax increased apoptosis by 3.3-fold (p ≤ 0.05) at Day 7 compared to monotherapy by cisplatin in HN30 and HN12 cells, however, it did not sensitize …
-
Development and validation of novel senolytic strategies for targeting and eliminating senescent cells
… (MMP-3). Basándose en esto, se cargaron MSNs con navitoclax y se recubrieron con un péptido específico de MMP-3 ( "puerta molecular"), obteniendo NPs(Nav)@MMP-3. Los estudios celulares demostraron una liberación preferencial de la carga en células senescentes en comparación con células …
-
Identifying the Mechanisms Behind Radiation Resistance in Treatment Naïve Diffuse Intrinsic Pontine Glioma Models
… and found that the pan BCL-2, BCL-xl inhibitor navitoclax was able to sensitize DIPG cells to radiation. We measured the percent of pro-apoptotic cells and found the combination of navitoclax and radiation significantly increase the percent of pro-apoptotic cells in the combination treatment …
-
MITOCHONDRIAL MARCH5 UBIQUITIN LIGASE ABROGATES MCL1-DEPENDENT RESISTANCE TO BH3 MIMETICS VIA STABILIZATION OF NOXA
… with sensitivity to the preclinical BH3 mimetic, navitoclax. Furthermore, we observed a synthetic lethal interaction between MCL1 and MARCH5 in MCL1-dependent breast cancer cells. Our data uncover a novel level at which the BCL2 family is regulated; furthermore, they suggest targeting …
-
Endplate Senescent Osteoclasts Induce Sensory Innervation and Spine Pain
… We show that administering a senolytic drug, Navitoclax (ABT263), eliminates the senescent osteoclast cells; as a result, it significantly reduces spinal hypersensitivity, spinal degeneration, the porosity of endplate, sensory nerve innervation, and H-type vessel growth in the endplate. …
-
Therapy-Induced Senescence in Cancer: Developing Senolytic-Based Combination Strategies to Delay Re-emergence of Triple-Negative Breast Cancer
… of TIS. Senolytic treatments with ABT-263 (navitoclax) produced only a transient clearance of senescent cells across the treatments with doxorubicin, hydroxy-peroxy-cyclophosphamide, 5-FU, paclitaxel and gemcitabine. Platinum-based agents yielded senescent populations that appeared to be …
-
MODULATION OF AUTOPHAGY AND SENESCENCE TO ENHANCE THE RESPONSE TO THERAPY IN TRIPLE NEGATIVE BREAST CANCER
… or radiation by the senolytic drug ABT-263 (Navitoclax). In summary, autophagy and senescence alone or in concert, can be induced by conventional anti-tumor modalities. Those processes can be modulated independently to achieve clearance of residual tumor cells following anti-cancer therapies.
-
Premature vascular senescence during diabetic retinopathy
… approach for elimination of senescent HRMECs. Navitoclax was found to be an effective senolytic for HRMECs<i> in vitro</i>.
-
pH and TRAIL receptors interplay in pancreatic ductal adenocarcinoma cells
… be sensitized to TRAIL by using an inhibitor (Navitoclax) of Bcl-xL, proving the importance of the mitochondrial amplification loop in (Type II) PDAC cells. Fourthly (4), Panc1 cells showed higher pHi values than Colo357 cells. (5) Increased NHE1, MCT4, and CAIX levels in Panc1 cells compared …
-
The Role of Cancer Associated Fibroblasts in Bone Invasive Oral Squamous Cell Carcinoma
… the senolytic drugs Alvespimycin (17-DMAG) and Navitoclax (ABT263). Moreover, to understand the mechanism by which OSCC and surrounding CAF communicate in the tumour microenvironment, EV were isolated from H357 oral cancer cell line, primary CAF from fresh OSCC tissue and experimentally induced …
-
Functional Genomics identify Novel Therapeutic Vulnerabilities in Retinoblastoma
… p21 or applying the BCL2/BCL2L1 inhibitor Navitoclax re-engaged the p53-BAX axis, and synergized with B02, TPT or both to overcome resistance. In addition, the in vivo screens confirmed essentiality of SKP2, a component of the multi-subunit Cullin Ring Ligases (CRLs) that ubiquitylate and …
-
A Subset of Senescent Myofibroblasts Orchestrates Immunosuppression in Pancreatic Cancer.
… the KPPC-IA model or the senolytic drug ABT263/Navitoclax, delayed tumor progression, reduced fibrosis, and relieved immune suppression in macrophages and T lymphocytes. Our findings demonstrate that SenCAFs promote PDAC progression, fibrosis, and immune cell dysfunction. Modulating CAF …
-
Combining Noxa-Inducing Drugs with ABT-263 to Efficiently Increase Cell Death in Head and Neck Squamous Cell Carcinoma (HNSCC)
… drugs: cisplatin, fenretinide, and ABT-263 (navitoclax). Both cisplatin and fenretinide are known to induce a BH3-only pro-apoptotic protein, Noxa, which binds to and inactivates multi-domain anti-apoptotic protein MCL-1 and release from its interaction with multi-domain pro-apoptotic protein …
-
Modulating type two alveolar epithelial senescence in acute lung injury and fibrosis
… susceptibility to the senolytic compound ABT263 (Navitoclax) invitro, which shows promise for further study. ARDS is classically considered to be neutrophil-mediated disease, with neutrophil elastase (NE)-null mice reported to show reduced levels of active TGF-β and pulmonary fibrosis. In-vitro …
Page 1 of 2